Literature DB >> 4054839

Hyperprolactinemia and sexual function in men.

J Buvat, A Lemaire, M Buvat-Herbaut, J C Fourlinnie, A Racadot, P Fossati.   

Abstract

Male hyperprolactinemia (HPRL) is known to induce different types of sexual dysfunctions. In order to determine the incidence of HPRL among patients referred for sexual dysfunction, serum prolactin (PRL) was assayed in 1053 clinically idiopathic cases. Among 850 cases complaining of erectile impotence, 10 with marked HPRL (1.1%, PRL above 35 ng/ml) were found, of whom 6 cases were associated with a pituitary adenoma. 17 mild HPRL (2%, PRL 20-35 ng/ml) were also found. Among 124 cases with premature ejaculation, 13 (10%) mild HPRL were found. Serum PRL was normal in 51 cases complaining of an ejaculation without orgasm, and 27 patients exclusively complaining of reduced sexual desire. Our results lay stress on the fact that serum PRL must be assayed in every case of clinically idiopathic erectile impotence. Indeed, 5 of the 10 marked HPRL patients would have been misdiagnosed if we had only assayed this hormone when plasma testosterone was below the normal range. Moreover, in order to shed some light on the mechanisms by which HPRL disturbs male sexual function, the sexual behaviour of 17 markedly HPRL males was compared to their serum levels of PRL and testosterone, first before treatment, then at regular intervals during treatment. Our main conclusion is that impotence cannot be totally explained by a decrease in plasma testosterone, because this steroid hormone was within the normal range 7 of the 16 impotent patients. Moreover, when serum PRL was lowered by bromocriptine, 6 patients recovered their potency before plasma testosterone clearly increased, and in 3 of those patients before it reached the normal range.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4054839     DOI: 10.1159/000180094

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  13 in total

1.  Single- and multiple-dose pharmacokinetics of ziprasidone under non-fasting conditions in healthy male volunteers.

Authors:  J J Miceli; K D Wilner; R A Hansen; A C Johnson; G Apseloff; N Gerber
Journal:  Br J Clin Pharmacol       Date:  2000       Impact factor: 4.335

2.  The anatomy of erection.

Authors:  G Benoit; V Delmas; C Gillot; A Jardin
Journal:  Surg Radiol Anat       Date:  1987       Impact factor: 1.246

Review 3.  Prolactinergic and dopaminergic mechanisms underlying sexual arousal and orgasm in humans.

Authors:  Tillmann H C Krüger; Uwe Hartmann; Manfred Schedlowski
Journal:  World J Urol       Date:  2005-05-12       Impact factor: 4.226

Review 4.  Growth hormone, prolactin, and sexuality.

Authors:  M Galdiero; R Pivonello; L F S Grasso; A Cozzolino; A Colao
Journal:  J Endocrinol Invest       Date:  2012-09       Impact factor: 4.256

5.  A prolactin-secreting tumor in a patient with Klinefelter's syndrome: a case report.

Authors:  A C Pinto; M A Czepielewski; J L Gross; W Mussio; A M Lengyel
Journal:  J Endocrinol Invest       Date:  1996-04       Impact factor: 4.256

6.  Plasma concentration of prolactin, testosterone might be associated with brain response to visual erotic stimuli in healthy heterosexual males.

Authors:  Younghee Seo; Bumseok Jeong; Ji-Woong Kim; Jeewook Choi
Journal:  Psychiatry Investig       Date:  2009-08-12       Impact factor: 2.505

7.  A systematic review of the correlates and management of nonpremature ejaculatory dysfunction in heterosexual men.

Authors:  Raouf Seyam
Journal:  Ther Adv Urol       Date:  2013-10

8.  Routine prolactin measurement is not necessary in the initial evaluation of male impotence.

Authors:  B E Akpunonu; A B Mutgi; D J Federman; J York; L S Woldenberg
Journal:  J Gen Intern Med       Date:  1994-06       Impact factor: 5.128

9.  Effect of blood sampling on apomorphine-induced penile tumescence in erectile impotence: a case report.

Authors:  M E Kiely; J X Thavundayil; S Lal
Journal:  J Psychiatry Neurosci       Date:  1995-05       Impact factor: 6.186

10.  Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone.

Authors:  Hong Liu-Seifert; Bruce J Kinon; Christopher J Tennant; Jennifer Sniadecki; Jan Volavka
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.